dipotassium;tert-butyl 7-(6-amino-3-pyridinyl)-2,7-diazaspiro[3.5]nonane-2-carboxylate;tert-butyl 2,7-diazaspiro[3.5]nonane-2-carboxylate;tert-butyl 7-(6-nitro-3-pyridinyl)-2,7-diazaspiro[3.5]nonane-2-carboxylate;7-(2,7-diazaspiro[3.5]nonan-7-yl)-2-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)pyrido[1,2-a]pyrimidin-4-one;ethyl 3-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)-3-oxopropanoate;5-fluoro-2-nitropyridine;hydride;oxido formate

C88H117FK2N22O17 — CID 158871660

IUPACdipotassium;tert-butyl 7-(6-amino-3-pyridinyl)-2,7-diazaspiro[3.5]nonane-2-carboxylate;tert-butyl 2,7-diazaspiro[3.5]nonane-2-carboxylate;tert-butyl 7-(6-nitro-3-pyridinyl)-2,7-diazaspiro[3.5]nonane-2-carboxylate;7-(2,7-diazaspiro[3.5]nonan-7-yl)-2-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)pyrido[1,2-a]pyrimidin-4-one;ethyl 3-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)-3-oxopropanoate;5-fluoro-2-nitropyridine;hydride;oxido formate
SMILESCC(C)(C)OC(=O)N1CC2(CCN(c3ccc(N)nc3)CC2)C1.CC(C)(C)OC(=O)N1CC2(CCN(c3ccc([N+](=O)[O-])nc3)CC2)C1.CC(C)(C)OC(=O)N1CC2(CCNCC2)C1.CCOC(=O)CC(=O)c1cc2c(C)nc(C)cn2n1.Cc1cn2nc(-c3cc(=O)n4cc(N5CCC6(CC5)CNC6)ccc4n3)cc2c(C)n1.O=CO[O-].O=[N+]([O-])c1ccc(F)cn1.[H-].[K+].[K+]
InChIInChI=1S/C23H25N7O.C17H24N4O4.C17H26N4O2.C13H15N3O3.C12H22N2O2.C5H3FN2O2.CH2O3.2K.H/c1-15-11-30-20(16(2)25-15)9-19(27-30)18-10-22(31)29-12-17(3-4-21(29)26-18)28-7-5-23(6-8-28)13-24-14-23;1-16(2,3)25-15(22)20-11-17(12-20)6-8-19(9-7-17)13-4-5-14(18-10-13)21(23)24;1-16(2,3)23-15(22)21-11-17(12-21)6-8-20(9-7-17)13-4-5-14(18)19-10-13;1-4-19-13(18)6-12(17)10-5-11-9(3)14-8(2)7-16(11)15-10;1-11(2,3)16-10(15)14-8-12(9-14)4-6-13-7-5-12;6-4-1-2-5(7-3-4)8(9)10;2-1-4-3;;;/h3-4,9-12,24H,5-8,13-14H2,1-2H3;4-5,10H,6-9,11-12H2,1-3H3;4-5,10H,6-9,11-12H2,1-3H3,(H2,18,19);5,7H,4,6H2,1-3H3;13H,4-9H2,1-3H3;1-3H;1,3H;;;/q;;;;;;;2*+1;-1/p-1
InChIKeyLSGLJNZGLQVGFJ-UHFFFAOYSA-M
MW1852.23 g/mol
LogP4.31
Rot. Bonds11

About dipotassium;tert-butyl 7-(6-amino-3-pyridinyl)-2,7-diazaspiro[3.5]nonane-2-carboxylate;tert-butyl 2,7-diazaspiro[3.5]nonane-2-carboxylate;tert-butyl 7-(6-nitro-3-pyridinyl)-2,7-diazaspiro[3.5]nonane-2-carboxylate;7-(2,7-diazaspiro[3.5]nonan-7-yl)-2-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)pyrido[1,2-a]pyrimidin-4-one;ethyl 3-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)-3-oxopropanoate;5-fluoro-2-nitropyridine;hydride;oxido formate

dipotassium;tert-butyl 7-(6-amino-3-pyridinyl)-2,7-diazaspiro[3.5]nonane-2-carboxylate;tert-butyl 2,7-diazaspiro[3.5]nonane-2-carboxylate;tert-butyl 7-(6-nitro-3-pyridinyl)-2,7-diazaspiro[3.5]nonane-2-carboxylate;7-(2,7-diazaspiro[3.5]nonan-7-yl)-2-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)pyrido[1,2-a]pyrimidin-4-one;ethyl 3-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)-3-oxopropanoate;5-fluoro-2-nitropyridine;hydride;oxido formate (PubChem CID 158871660) has the molecular formula C88H117FK2N22O17 and a molecular weight of 1852.23 g/mol. Its IUPAC name is dipotassium;tert-butyl 7-(6-amino-3-pyridinyl)-2,7-diazaspiro[3.5]nonane-2-carboxylate;tert-butyl 2,7-diazaspiro[3.5]nonane-2-carboxylate;tert-butyl 7-(6-nitro-3-pyridinyl)-2,7-diazaspiro[3.5]nonane-2-carboxylate;7-(2,7-diazaspiro[3.5]nonan-7-yl)-2-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)pyrido[1,2-a]pyrimidin-4-one;ethyl 3-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)-3-oxopropanoate;5-fluoro-2-nitropyridine;hydride;oxido formate.

Molecular Properties

Compound Namedipotassium;tert-butyl 7-(6-amino-3-pyridinyl)-2,7-diazaspiro[3.5]nonane-2-carboxylate;tert-butyl 2,7-diazaspiro[3.5]nonane-2-carboxylate;tert-butyl 7-(6-nitro-3-pyridinyl)-2,7-diazaspiro[3.5]nonane-2-carboxylate;7-(2,7-diazaspiro[3.5]nonan-7-yl)-2-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)pyrido[1,2-a]pyrimidin-4-one;ethyl 3-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)-3-oxopropanoate;5-fluoro-2-nitropyridine;hydride;oxido formate
PubChem CID158871660
Molecular FormulaC88H117FK2N22O17
Molecular Weight1852.23 g/mol
Exact Mass1850.82
IUPAC Namedipotassium;tert-butyl 7-(6-amino-3-pyridinyl)-2,7-diazaspiro[3.5]nonane-2-carboxylate;tert-butyl 2,7-diazaspiro[3.5]nonane-2-carboxylate;tert-butyl 7-(6-nitro-3-pyridinyl)-2,7-diazaspiro[3.5]nonane-2-carboxylate;7-(2,7-diazaspiro[3.5]nonan-7-yl)-2-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)pyrido[1,2-a]pyrimidin-4-one;ethyl 3-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)-3-oxopropanoate;5-fluoro-2-nitropyridine;hydride;oxido formate
SMILESCC(C)(C)OC(=O)N1CC2(CCN(c3ccc(N)nc3)CC2)C1.CC(C)(C)OC(=O)N1CC2(CCN(c3ccc([N+](=O)[O-])nc3)CC2)C1.CC(C)(C)OC(=O)N1CC2(CCNCC2)C1.CCOC(=O)CC(=O)c1cc2c(C)nc(C)cn2n1.Cc1cn2nc(-c3cc(=O)n4cc(N5CCC6(CC5)CNC6)ccc4n3)cc2c(C)n1.O=CO[O-].O=[N+]([O-])c1ccc(F)cn1.[H-].[K+].[K+]
InChIInChI=1S/C23H25N7O.C17H24N4O4.C17H26N4O2.C13H15N3O3.C12H22N2O2.C5H3FN2O2.CH2O3.2K.H/c1-15-11-30-20(16(2)25-15)9-19(27-30)18-10-22(31)29-12-17(3-4-21(29)26-18)28-7-5-23(6-8-28)13-24-14-23;1-16(2,3)25-15(22)20-11-17(12-20)6-8-19(9-7-17)13-4-5-14(18-10-13)21(23)24;1-16(2,3)23-15(22)21-11-17(12-21)6-8-20(9-7-17)13-4-5-14(18)19-10-13;1-4-19-13(18)6-12(17)10-5-11-9(3)14-8(2)7-16(11)15-10;1-11(2,3)16-10(15)14-8-12(9-14)4-6-13-7-5-12;6-4-1-2-5(7-3-4)8(9)10;2-1-4-3;;;/h3-4,9-12,24H,5-8,13-14H2,1-2H3;4-5,10H,6-9,11-12H2,1-3H3;4-5,10H,6-9,11-12H2,1-3H3,(H2,18,19);5,7H,4,6H2,1-3H3;13H,4-9H2,1-3H3;1-3H;1,3H;;;/q;;;;;;;2*+1;-1/p-1
InChIKeyLSGLJNZGLQVGFJ-UHFFFAOYSA-M
XLogP4.31
TPSA460.85 Ų
H-Bond Donors3
H-Bond Acceptors34
Rotatable Bonds11
Heavy Atoms130
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001852.23
LogP ≤ 54.31
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1034

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}, {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze dipotassium;tert-butyl 7-(6-amino-3-pyridinyl)-2,7-diazaspiro[3.5]nonane-2-carboxylate;tert-butyl 2,7-diazaspiro[3.5]nonane-2-carboxylate;tert-butyl 7-(6-nitro-3-pyridinyl)-2,7-diazaspiro[3.5]nonane-2-carboxylate;7-(2,7-diazaspiro[3.5]nonan-7-yl)-2-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)pyrido[1,2-a]pyrimidin-4-one;ethyl 3-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)-3-oxopropanoate;5-fluoro-2-nitropyridine;hydride;oxido formate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of dipotassium;tert-butyl 7-(6-amino-3-pyridinyl)-2,7-diazaspiro[3.5]nonane-2-carboxylate;tert-butyl 2,7-diazaspiro[3.5]nonane-2-carboxylate;tert-butyl 7-(6-nitro-3-pyridinyl)-2,7-diazaspiro[3.5]nonane-2-carboxylate;7-(2,7-diazaspiro[3.5]nonan-7-yl)-2-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)pyrido[1,2-a]pyrimidin-4-one;ethyl 3-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)-3-oxopropanoate;5-fluoro-2-nitropyridine;hydride;oxido formate?
The IUPAC name of dipotassium;tert-butyl 7-(6-amino-3-pyridinyl)-2,7-diazaspiro[3.5]nonane-2-carboxylate;tert-butyl 2,7-diazaspiro[3.5]nonane-2-carboxylate;tert-butyl 7-(6-nitro-3-pyridinyl)-2,7-diazaspiro[3.5]nonane-2-carboxylate;7-(2,7-diazaspiro[3.5]nonan-7-yl)-2-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)pyrido[1,2-a]pyrimidin-4-one;ethyl 3-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)-3-oxopropanoate;5-fluoro-2-nitropyridine;hydride;oxido formate (CID 158871660) is dipotassium;tert-butyl 7-(6-amino-3-pyridinyl)-2,7-diazaspiro[3.5]nonane-2-carboxylate;tert-butyl 2,7-diazaspiro[3.5]nonane-2-carboxylate;tert-butyl 7-(6-nitro-3-pyridinyl)-2,7-diazaspiro[3.5]nonane-2-carboxylate;7-(2,7-diazaspiro[3.5]nonan-7-yl)-2-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)pyrido[1,2-a]pyrimidin-4-one;ethyl 3-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)-3-oxopropanoate;5-fluoro-2-nitropyridine;hydride;oxido formate.
What is the SMILES notation for dipotassium;tert-butyl 7-(6-amino-3-pyridinyl)-2,7-diazaspiro[3.5]nonane-2-carboxylate;tert-butyl 2,7-diazaspiro[3.5]nonane-2-carboxylate;tert-butyl 7-(6-nitro-3-pyridinyl)-2,7-diazaspiro[3.5]nonane-2-carboxylate;7-(2,7-diazaspiro[3.5]nonan-7-yl)-2-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)pyrido[1,2-a]pyrimidin-4-one;ethyl 3-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)-3-oxopropanoate;5-fluoro-2-nitropyridine;hydride;oxido formate?
The canonical SMILES for dipotassium;tert-butyl 7-(6-amino-3-pyridinyl)-2,7-diazaspiro[3.5]nonane-2-carboxylate;tert-butyl 2,7-diazaspiro[3.5]nonane-2-carboxylate;tert-butyl 7-(6-nitro-3-pyridinyl)-2,7-diazaspiro[3.5]nonane-2-carboxylate;7-(2,7-diazaspiro[3.5]nonan-7-yl)-2-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)pyrido[1,2-a]pyrimidin-4-one;ethyl 3-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)-3-oxopropanoate;5-fluoro-2-nitropyridine;hydride;oxido formate is CC(C)(C)OC(=O)N1CC2(CCN(c3ccc(N)nc3)CC2)C1.CC(C)(C)OC(=O)N1CC2(CCN(c3ccc([N+](=O)[O-])nc3)CC2)C1.CC(C)(C)OC(=O)N1CC2(CCNCC2)C1.CCOC(=O)CC(=O)c1cc2c(C)nc(C)cn2n1.Cc1cn2nc(-c3cc(=O)n4cc(N5CCC6(CC5)CNC6)ccc4n3)cc2c(C)n1.O=CO[O-].O=[N+]([O-])c1ccc(F)cn1.[H-].[K+].[K+].
What is the InChIKey of dipotassium;tert-butyl 7-(6-amino-3-pyridinyl)-2,7-diazaspiro[3.5]nonane-2-carboxylate;tert-butyl 2,7-diazaspiro[3.5]nonane-2-carboxylate;tert-butyl 7-(6-nitro-3-pyridinyl)-2,7-diazaspiro[3.5]nonane-2-carboxylate;7-(2,7-diazaspiro[3.5]nonan-7-yl)-2-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)pyrido[1,2-a]pyrimidin-4-one;ethyl 3-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)-3-oxopropanoate;5-fluoro-2-nitropyridine;hydride;oxido formate?
The InChIKey is LSGLJNZGLQVGFJ-UHFFFAOYSA-M. The full InChI is InChI=1S/C23H25N7O.C17H24N4O4.C17H26N4O2.C13H15N3O3.C12H22N2O2.C5H3FN2O2.CH2O3.2K.H/c1-15-11-30-20(16(2)25-15)9-19(27-30)18-10-22(31)29-12-17(3-4-21(29)26-18)28-7-5-23(6-8-28)13-24-14-23;1-16(2,3)25-15(22)20-11-17(12-20)6-8-19(9-7-17)13-4-5-14(18-10-13)21(23)24;1-16(2,3)23-15(22)21-11-17(12-21)6-8-20(9-7-17)13-4-5-14(18)19-10-13;1-4-19-13(18)6-12(17)10-5-11-9(3)14-8(2)7-16(11)15-10;1-11(2,3)16-10(15)14-8-12(9-14)4-6-13-7-5-12;6-4-1-2-5(7-3-4)8(9)10;2-1-4-3;;;/h3-4,9-12,24H,5-8,13-14H2,1-2H3;4-5,10H,6-9,11-12H2,1-3H3;4-5,10H,6-9,11-12H2,1-3H3,(H2,18,19);5,7H,4,6H2,1-3H3;13H,4-9H2,1-3H3;1-3H;1,3H;;;/q;;;;;;;2*+1;-1/p-1.
What are the key properties of dipotassium;tert-butyl 7-(6-amino-3-pyridinyl)-2,7-diazaspiro[3.5]nonane-2-carboxylate;tert-butyl 2,7-diazaspiro[3.5]nonane-2-carboxylate;tert-butyl 7-(6-nitro-3-pyridinyl)-2,7-diazaspiro[3.5]nonane-2-carboxylate;7-(2,7-diazaspiro[3.5]nonan-7-yl)-2-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)pyrido[1,2-a]pyrimidin-4-one;ethyl 3-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)-3-oxopropanoate;5-fluoro-2-nitropyridine;hydride;oxido formate?
dipotassium;tert-butyl 7-(6-amino-3-pyridinyl)-2,7-diazaspiro[3.5]nonane-2-carboxylate;tert-butyl 2,7-diazaspiro[3.5]nonane-2-carboxylate;tert-butyl 7-(6-nitro-3-pyridinyl)-2,7-diazaspiro[3.5]nonane-2-carboxylate;7-(2,7-diazaspiro[3.5]nonan-7-yl)-2-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)pyrido[1,2-a]pyrimidin-4-one;ethyl 3-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)-3-oxopropanoate;5-fluoro-2-nitropyridine;hydride;oxido formate has a molecular weight of 1852.23 g/mol, XLogP of 4.31, 11 rotatable bonds, 3 hydrogen bond donors, and 34 hydrogen bond acceptors.
Where does this data come from?
All data for dipotassium;tert-butyl 7-(6-amino-3-pyridinyl)-2,7-diazaspiro[3.5]nonane-2-carboxylate;tert-butyl 2,7-diazaspiro[3.5]nonane-2-carboxylate;tert-butyl 7-(6-nitro-3-pyridinyl)-2,7-diazaspiro[3.5]nonane-2-carboxylate;7-(2,7-diazaspiro[3.5]nonan-7-yl)-2-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)pyrido[1,2-a]pyrimidin-4-one;ethyl 3-(4,6-dimethylpyrazolo[1,5-a]pyrazin-2-yl)-3-oxopropanoate;5-fluoro-2-nitropyridine;hydride;oxido formate is sourced from PubChem (CID 158871660), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).